AVTX: Philip Ron M discloses securities transactions

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Philip Ron M

Reporting filer

Philip Ron M reported Grant or award in Avalo Therapeutics, Inc.: 1109 units of Stock Option (Right to Buy) (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (Right to Buy) (derivative)	Philip Ron M	2026-09-30	A	Grant or award	1109	12.29	1,109	2 days	Filed terms security Title: Stock Option (Right to Buy) conversion Or Exercise Price: 15.33 transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 1109 transaction Price Per Share: 12.29 id: F2 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-09-30 underlying Security Title: Common Stock underlying Security Shares: 1109 shares Owned Following Transaction: 1109 direct Or Indirect Ownership: D nature Of Ownership:

Stock Option (Right to Buy) (derivative)

Owner: Philip Ron M
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 1109
Price: 12.29
Following holdings: 1,109
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 15.33
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 1109
transaction Price Per Share: 12.29
id: F2
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-30
underlying Security Title: Common Stock
underlying Security Shares: 1109
shares Owned Following Transaction: 1109
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Philip Ron M: Director.
F1: The options were granted on September 30, 2026, and are 100% vested.
F2: The options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Plan in lieu of Board fees.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Option (Right to Buy) (derivative)

Philip Ron M

2026-09-30

Grant or award

1109

12.29

1,109

2 days

Filed terms

security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 15.33
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 1109
transaction Price Per Share: 12.29
id: F2
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-30
underlying Security Title: Common Stock
underlying Security Shares: 1109
shares Owned Following Transaction: 1109
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Philip Ron M: Director.

F1: The options were granted on September 30, 2026, and are 100% vested.

F2: The options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Plan in lieu of Board fees.